Latest Regenerative September 24, 2025 News

Xintela’s Knee Osteoarthritis Stem Cell Product Shows Safety and Positive Efficacy After Two Years

Patients receiving XSTEM’s highest dose reported ongoing pain relief and joint improvement two years after a single treatment.

Orthopedic

September 24, 2025

Pluristyx and Solesis Partner on Stem Cell Research and Organoid Development

The partnership aims to deliver standardized tools for stem cell and organoid research, addressing reproducibility and scalability challenges.

iPSC, Manufacturing

September 24, 2025

RBI Launching Phase 2 Brain Stem Cell Injection Trial for Alzheimer’s

The trial will inject autologous stem cells directly into the brain to bypass the blood-brain-barrier.

Neurology

September 24, 2025